Citation Impact
Citing Papers
Prevalence of scleroderma spectrum disorders in the general population of south carolina
1989
Gastrointestinal motility disorders in scleroderma
1994 Standout
The Systemic Amyloidoses
1997 Standout
Sjögren's syndrome
2005 Standout
Paraquat Poisonings: Mechanisms of Lung Toxicity, Clinical Features, and Treatment
2007 Standout
EPIDEMIOLOGY OF THE VASCULITIDES
2001
Epidemiological study of patients with systemic sclerosis in Tokyo
1991
Incidence of systemic lupus erythematosus race and gender differences
1995
The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis
1990 Standout
Association between radiographic features of knee osteoarthritis and pain: results from two cohort studies
2009 Standout
Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis
2004 Standout
The Epidemiology of low back pain
2010 Standout
Scleroderma
2009 Standout
TFOS DEWS II pathophysiology report
2017 Standout
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)
2006 Standout
Sex differences in HPA axis responses to stress: a review
2004 Standout
Incidence of Physician-Diagnosed Primary Sjögren Syndrome in Residents of Olmsted County, Minnesota
2001
TFOS DEWS II Epidemiology Report
2017 Standout
Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States
1998 Standout
Investigation of a unilateral pleural effusion in adults: British Thoracic Society pleural disease guideline 2010
2010 Standout
Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis
2000 Standout
The Role of Knee Alignment in Disease Progression and Functional Decline in Knee Osteoarthritis
2001 Standout
The epidemiology of giant cell arteritis
2001
Immune Thrombocytopenic Purpura
2002 Standout
The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review
2011 Standout
Takayasu's Arteritis and Temporal Arteritis
1992
Systemic amyloidosis
2015 Standout
Systemic sclerosis: a prototypic multisystem fibrotic disorder
2007 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Infections in Patients with Diabetes Mellitus
1999 Standout
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I
2007 Standout
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II
2007 Standout
Polymyalgia Rheumatica and Giant-Cell Arteritis
2002 Standout
Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial
2001 Standout
Sex differences in immune responses
2016 Standout
Rituximab in the treatment of dermatomyositis: An open‐label pilot study
2005
A connective tissue disease screening questionnaire for population studies
1995
Epidemiology and Estimated Population Burden of Selected Autoimmune Diseases in the United States
1997 Standout
Incidence and Prevalence of Systemic Sclerosis: A Systematic Literature Review
2007
Impact of Gender, Menstrual Cycle Phase, and Oral Contraceptives on the Activity of the Hypothalamus-Pituitary-Adrenal Axis
1999 Standout
Molecular Mechanisms of Amyloidosis
2003 Standout
Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population
2003 Standout
The epidemiology of systemic sclerosis (scleroderma) among male U.S. veterans
1978
Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989 [see comments]
1992
The epidemiology of giant cell arteritis. Report of a Ten‐Year Study in Shelby County, Tennessee
1983
Rheumatoid pleural effusion.
1971
IMMUNOSUPPRESSIVE DRUG THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
1994
Augmentation of T Cell Levels and Responses Induced by Androgen Deprivation
2004 StandoutNobel
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Prevalence and Mortality Rates of Systemic Lupus Erythematosus and Causes of Death in SLE Patients in Finland
1985
Epidemiology and Natural History of Systemic Sclerosis
1990
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
The Spectrum of Vasculitis
1978 Standout
The gastrointestinal manifestations of scleroderma: Pathogenesis and management
1980 Standout
Temporal Arteritis
1978
Incidence of Physician-Diagnosed Primary Sjögren Syndrome in Residents of Olmsted County, Minnesota
2001
Thoracic and Abdominal Aortic Aneurysms
2005 Standout
The epidemiology of systemic lupus erythematosus
1973
Familial aggregation of polymyalgia rheumatica and giant cell arteritis
1974
Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992
1999
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Pathogenesis of systemic sclerosis: A vascular hypothesis
1975
Following the Molecular Pathways toward an Understanding of the Pathogenesis of Systemic Sclerosis
2004 Standout
Prevalence of Raynaud phenomenon in the general population
1986
Brief Report: Testosterone Is Protective in the Sexually Dimorphic Development of Arthritis and Lung Disease in SKG Mice
2013 StandoutNobel
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
2003 Standout
MANAGEMENT OF CHILDHOOD IDIOPATHIC THROMBOCYTOPENIC PURPURA
1983
Epidemiology of Systemic Lupus Erythematosus and Other Connective Tissue Diseases in Rochester, Minnesota, 1950 Through 1979
1985
SOFT TISSUE INFECTIONS
1993
Works of Ferguson Rh being referenced
Progressive lupus glomerulonephritis. Treatment with prednisone and combined prednisone and cyclophosphamide.
1976
Epidemiologic features of diffuse connective tissue disorders in Rochester, Minn., 1951 through 1967, with special reference to systemic lupus erythematosus.
1969
Frentizole therapy of thrombocytopenia in systemic lupus erythematosus and refractory idiopathic thrombocytopenic purpura.
1980
Temporal arteritis in Rochester, Minnesota, 1951 to 1967.
1971
Tuberculous fasciitis with tenosynovitis.
1987
Pleuropulmonary manifestations of ankylosing spondylitis.
1977